E
EyePoint Pharmaceuticals, Inc.
EYPT · NASDAQ · Healthcare · 1.2B
Closing price
$3.40
-1.73% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.8×
Enterprise value / EBITDAEV/EBITDA
-0.7×
Free cash flow yieldFCF yield
-97.7%
Return on equityROE
-75.8%
Operating margin
-776.0%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.